ArcticZymes Technologies ASA (LON:0DRV)

Market Cap	61.41M
Revenue (ttm)	7.58M
Net Income (ttm)	161.28K
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	380.77
Forward PE	113.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	391
Average Volume	951
Open	17.30
Previous Close	16.95
Day's Range	17.30 - 17.30
52-Week Range	0.92 - 2.90
Beta	0.75
RSI	52.35
Earnings Date	May 8, 2025

About LON:0DRV

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 54
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DRV

Financial Performance

In 2024, LON:0DRV's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.

Financial numbers in NOK